Shop
eStoreRx™
Online Supplement Dispensary
eStoreRx™ is an easy direct-to-patient ordering & fulfilment program for lifelong wellness.
For over 40 years, Biotics Research Corporation has revolutionized the nutritional supplement industry by utilizing “The Best of Science and Nature”. Combining nature’s principles with scientific ingenuity, our products magnify the nutritional
eStoreRx™ is an easy direct-to-patient ordering & fulfilment program for lifelong wellness.
Biotics Research is proud to expand our commitment to education with the Wellness Unfiltered Pro Podcast. Each episode delves into key health topics and the clinical applications of our premier products. Through candid, insightful conversations, our team offers practical guidance to keep you informed and empowered as a healthcare professional.
December 20 2024
The British Journal of Sports Medicine recently published a systematic review that analyzed the effects of postpartum exercise on maternal postpartum ...
Evidence shows that gut microbes are key factors involved in regulating energy homeostasis, metabolic inflammation, lipid metabolism, and glucose metabolism. Researchers conducted a study to evaluate the impact of S boulardii on obesity and associated metabolic features including fat mass development, hepatic steatosis, and low-grade inflammation in obese mice. S. boulardii was administer orally each day to leptin-resistance obese and type 2 diabetic (T2D) mice for 4 weeks. S. boulardii treated mice exhibited reduced body weight, fat mass, hepatic steatosis and inflammatory tone. These effects on host metabolism were associated with local effects in the intestine. S. boulardii increased cecum weight and cecum tissue weight but also induced dramatic changes in the gut microbial composition at the phylum, family, and genus levels. These changes may also be correlated with the host metabolism response. Researchers concluded that their study demonstrated for the first time that S. boulardii may act as a beneficial treatment in the context of obesity and T2D.
Everard A, et al. 2014. Saccharomyces boulardii Administration Changes Gut Microbiota and Reduces Hepatic Steatosis, Low-Grade Inflammation, and Fat Mass in Obese and Type 2 Diabetic db/db Mice. mBio 5(3):e01011-14. doi:10.1128/mBio.010011-14. Published 10 June 2014.
Submit this form and you'll receive our latest news and updates.
*These statements have not been evaluated by the Food and Drug Administration. This product has not intended to diagnose, treat, cure, or prevent any disease.
© 2023 Biotics Research Corporation - All Rights Reserved
Submit your comment